These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6511284)

  • 1. Labetolol in patients with hypertension and varying degrees of renal impairment.
    Breen EG; Lombard M; Watson A; Keogh JA
    Ir J Med Sci; 1984 Oct; 153(10):336-42. PubMed ID: 6511284
    [No Abstract]   [Full Text] [Related]  

  • 2. Labetalol in the treatment of patients with hypertension and renal function impairment.
    Bailey RR
    Br J Clin Pharmacol; 1979; 8(Suppl 2):135S-140S. PubMed ID: 526393
    [No Abstract]   [Full Text] [Related]  

  • 3. [Labetolol in the therapy of secondary arterial hypertension. A polycentric study].
    Palla R; Giusti R; Marchitiello M; Menicucci R
    Minerva Nefrol; 1982; 29(2):105-10. PubMed ID: 7133539
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effects of prolonged treatment with labetalol on renal function and on water and saline metabolism in essential and reno-parenchymal hypertension].
    Valvo E; Tessitore N; Previato G; Lupo A; Lo Schiavo C; Tornieri G; Maschio G
    Minerva Nefrol; 1979; 26(1):1-3. PubMed ID: 471316
    [No Abstract]   [Full Text] [Related]  

  • 5. The short term effects of oral labetalol in patients with chronic renal disease and hypertension.
    Innes A; Gemmell HG; Smith FW; Edward N; Catto GR
    J Hum Hypertens; 1992 Jun; 6(3):211-4. PubMed ID: 1629891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monotherapy with labetalol for hypertensive patients with normal and impaired renal function.
    Thompson FD; Joekes AM; Hussein MM
    Br J Clin Pharmacol; 1979; 8(Suppl 2):129S-133S. PubMed ID: 526392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of chronic alpha and beta adrenoceptor blockade with labetalol on plasma catecholamines and renal function in hypertension.
    Keusch G; Weidmann P; Ziegler WH; de Châtel R; Reubi FC
    Klin Wochenschr; 1980 Jan; 58(1):25-9. PubMed ID: 7374093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative study of labetolol and propranolol in patients with untreated hypertension].
    Wessel-Aas T; Walstad RA; Berg KJ
    Tidsskr Nor Laegeforen; 1981 Mar; 101(9-10):579-81. PubMed ID: 7221994
    [No Abstract]   [Full Text] [Related]  

  • 9. Blood pressure, plasma volume, extracellular volume and glomerular filtration rate during treatment with labetalol in essential hypertension.
    Rasmussen S; Nielsen PE
    Postgrad Med J; 1980; 56 Suppl 2():33-6. PubMed ID: 7433340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of propranolol and labetalol on renal haemodynamics at rest and during exercise in essential hypertension.
    Pedersen EB; Larsen JS
    Postgrad Med J; 1980; 56 Suppl 2():27-32. PubMed ID: 7433339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Labetolol--combined alpha and beta blockade for hypertension.
    Raftery EB
    Scott Med J; 1978 Oct; 23(4):279-80. PubMed ID: 31683
    [No Abstract]   [Full Text] [Related]  

  • 12. Evolution of renal function under chronic oral administration of labetalol.
    Labeeuw M; Zech P; Pozet N; Hadj-Aissa A; Traeger J
    Int J Clin Pharmacol Ther Toxicol; 1987 Jan; 25(1):23-5. PubMed ID: 3557725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of treatment with labetalol on renal function in arterial hypertension secondary to parenchymal nephropathy and in essential arterial hypertension].
    Palla R; Bionda A; Carmassi F; Giusti R; Marchitiello M
    Recenti Prog Med; 1980 Nov; 69(5):551-5. PubMed ID: 7465989
    [No Abstract]   [Full Text] [Related]  

  • 14. Blood pressure, body fluid volumes and glomerular filtration rate during treatment with labetalol in essential hypertension.
    Rasmussen S; Nielsen PE
    Br J Clin Pharmacol; 1981 Sep; 12(3):349-53. PubMed ID: 7295465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of nebivolol on dynamics of microalbuminuria, renal blood flow and 24-hour blood pressure profile in patients with hypertension].
    Gromnatskiĭ NI; Vasil'eva DA
    Kardiologiia; 2002; 42(9):53-6. PubMed ID: 12494075
    [No Abstract]   [Full Text] [Related]  

  • 16. Labetalol and renal function.
    Watson A; Maher K; Keogh JA
    Ir J Med Sci; 1981 Jun; 150(6):174-7. PubMed ID: 7275562
    [No Abstract]   [Full Text] [Related]  

  • 17. [Labetalol in ambulatory therapy of hypertension].
    Zilcher H; Weber H; Glogar D
    Wien Med Wochenschr Suppl; 1981; 69():23-4. PubMed ID: 6952656
    [No Abstract]   [Full Text] [Related]  

  • 18. A five-year study of labetalol in hypertension.
    Kane J; Gregg I; Stephens MD
    Practitioner; 1981 Jan; 225(1351):97-8, 100. PubMed ID: 7220466
    [No Abstract]   [Full Text] [Related]  

  • 19. [Labetalol in the treatment of resistant hypertension].
    Krechnáková A; Danĕková H; Nandoryová M; Niederland TR
    Vnitr Lek; 1981 Jul; 27(7):660-6. PubMed ID: 7303500
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of hypertension by labetalol (author's transl)].
    Sternon J; Melot C; Contu E
    Rev Med Brux; 1980 Nov; 1(9):615-21. PubMed ID: 7455430
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.